[The evaluation of urinary tract dysfunction in children with monosymptomatic primary nocturnal enuresis]. 2008

Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
I Klinika Chorób Dzieci AM w Białymstoku. iklinped@amnb.edu.pl

The reason for our search was various investigations about urinary tract dysfunctions in enuretic children. OBJECTIVE The aim of our study was estimation of lover urinary tract function in children with monosymptomatic primary nocturnal enuresis without positive reaction for a long non pharmacological therapy. METHODS 54 children after 9-12 months behavioral therapy and short pharmacological treatment (desmopresin) was undergoing urodynamic investigation (uroflowmetry and cystometry). RESULTS Urodynamic disorders was found in 44/54 of estimated children. In 34 of children it was overactive bladder, in 6 patients we found detrusor-sphincter discoordination. Five children had decreased bladder capacity. Next to non pharmacological treatment we used anticholinergic or Baclofen depending on the results of urodynamic tests. The response to the treatment (non bedwetting at all) we observed in 34 children (in 9 of them after 3 months of therapy, in 16 after 6 months of therapy and in 12 after 12 months of therapy). The rest of children had decreased number of wet night per month. CONCLUSIONS The pharmacological treatment of urodynamic disorders helps to children with monosymptomatic primary nocturnal enuresis to lost this symptom.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003894 Deamino Arginine Vasopressin A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. Desmopressin,Vasopressin, Deamino Arginine,1-Deamino-8-D-arginine Vasopressin,1-Desamino-8-arginine Vasopressin,Adiuretin,Adiuretin SD,Apo-Desmopressin,DDAVP,Desmogalen,Desmopressin Acetate,Desmopressin Monoacetate,Desmopressin Monoacetate, Trihydrate,Desmopressine Ferring,Desmospray,Desmotabs,Minirin,Minurin,Nocutil,Octim,Octostim,Acetate, Desmopressin,Arginine Vasopressin, Deamino,Ferring, Desmopressine,Monoacetate, Desmopressin,Monoacetate, Trihydrate Desmopressin,Trihydrate Desmopressin Monoacetate,Vasopressin, 1-Deamino-8-D-arginine,Vasopressin, 1-Desamino-8-arginine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001418 Baclofen A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission. Baclophen,Chlorophenyl GABA,Apo-Baclofen,Atrofen,Ba-34,647,Ba-34647,Baclofen AWD,Baclofène-Irex,Baclospas,CIBA-34,647-BA,Clofen,Gen-Baclofen,Genpharm,Lebic,Lioresal,Liorésal,Nu-Baclo,PCP-GABA,PMS-Baclofen,beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid,beta-(p-Chlorophenyl)-gamma-aminobutyric Acid,AWD, Baclofen,Apo Baclofen,ApoBaclofen,Ba34,647,Ba34647,Baclofène Irex,BaclofèneIrex,CIBA34,647BA,GABA, Chlorophenyl,Gen Baclofen,GenBaclofen,Nu Baclo,NuBaclo,PMS Baclofen,PMSBaclofen
D014563 Urodynamics The mechanical laws of fluid dynamics as they apply to urine transport. Urodynamic
D014570 Urologic Diseases Pathological processes of the URINARY TRACT in both males and females. Urinary Tract Diseases,Urological Diseases,Disease, Urinary Tract,Disease, Urologic,Disease, Urological,Diseases, Urinary Tract,Diseases, Urologic,Diseases, Urological,Urinary Tract Disease,Urologic Disease,Urological Disease
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D050034 Antidiuretic Agents Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS. Anti-Diuretic Agents,Antidiuretic Effect,Antidiuretic Effects,Agents, Anti-Diuretic,Agents, Antidiuretic,Anti Diuretic Agents,Effect, Antidiuretic,Effects, Antidiuretic

Related Publications

Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
October 2001, Urology,
Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
September 1999, The Journal of urology,
Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
August 2006, The Journal of urology,
Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
January 2024, Turkish journal of medical sciences,
Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
January 2021, Comprehensive psychiatry,
Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
September 2007, International journal of clinical practice. Supplement,
Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
January 2019, International braz j urol : official journal of the Brazilian Society of Urology,
Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
December 2014, Journal of pediatric urology,
Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
January 2023, Clinical pediatrics,
Agata Korzeniecka-Kozerska, and Walentyna Zoch-Zwierz, and Anna Wasilewska, and Tadeusz Porowski
January 2013, Medycyna wieku rozwojowego,
Copied contents to your clipboard!